// App-Quantinova.ai

BSH19‐OR‐016 : Introducing Self Administration of Bortezomib (Velcade) to Myeloma Patients

Researchers

Presenter

  • T. Burton

Principal Investigators

  • C. Bygrave

Medical Centers

  • haematology, cardiff and vale, cardiff, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Peripheral Nervous System

  • Oncology (ONC)

Disease

  • Peripheral neuropathy

  • Multiple Myeloma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Bortezomib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved